Patients with acute and chronic coronary syndrome are at long-term risk of cardiovascular events, despite the advances in the management with revascularization strategies and antiplatelet therapy with aspirin and P2Y12 receptor antagonist. In this regard, Access 360 and Docplexus have organized an interactive LIVE webinar on 9th October 2020, Friday, 7.00 PM onwards. To gain more insights on this topic, please join our experts Dr. S. A.
Merchant who will be discussing “ACS- Interventions & Pharmacotherapy”, and Dr. Anil Sharma who will be sharing insights on “Chronic Coronary Syndrome Management Conservative vs Interventional.” Reference Yip C, Seneviratna A, Tan SH, Khaing T, Chan SP, Loh J, Lee CH, Low AF, Drum CL, Poh SC, Gibson CM. Patients with acute and chronic coronary syndromes have elevated long-term thrombin generation. Journal of Thrombosis and Thrombolysis. 2020 Feb 19:1-9.
